Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dragos Apostu, Ondine Lucaciu, Alexandru Mester, Horea Benea, Daniel Oltean-Dan, Florin Onisor, Mihaela Baciut & Simion Bran. (2019) Cannabinoids and bone regeneration. Drug Metabolism Reviews 51:1, pages 65-75.
Read now
Read now
Joanna Makowiecka & Karolina Wielgus. (2014) Therapeutic Potential of Cannabinoids—Perspectives for the Future. Journal of Natural Fibers 11:4, pages 283-311.
Read now
Read now
Ioanna Vasileiou, Georgia Fotopoulou, Marina Matzourani, Efstratios Patsouris & Stamatios Theocharis. (2013) Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases. Expert Opinion on Therapeutic Targets 17:4, pages 363-377.
Read now
Read now
Itai Bab & Orr Ofek. (2011) Targeting the CB2 cannabinoid receptor in osteoporosis. Expert Review of Endocrinology & Metabolism 6:2, pages 135-138.
Read now
Read now
Articles from other publishers (73)
Rivka Ihejirika-Lomedico & Harold Fogel. (2023) Cannabinoids in Spine Surgery: A Comprehensive Review. Operative Techniques in Orthopaedics 33:4, pages 101065.
Crossref
Crossref
Si-jing Hu, Gang Cheng, Gao-ce Chen, Hao Zhou, Qi Zhang, Qi-ming Zhao, Chen-xia Lian, Zi-hui Zhao, Quan-long Zhang, Ting Han, Qiao-yan Zhang & Lu-ping Qin. (2023) Cannabinoid receptors type 2: Function and Development in Agonist Discovery from synthetic and natural sources with Applications for the Therapy of Osteoporosis. Arabian Journal of Chemistry, pages 105536.
Crossref
Crossref
Yao Xiao, Changhao Han, Yunhao Wang, Xinshu Zhang, Rong Bao, Yuange Li, Huajiang Chen, Bo Hu & Shen Liu. (2023) Interoceptive regulation of skeletal tissue homeostasis and repair. Bone Research 11:1.
Crossref
Crossref
Rivka Ihejirika-Lomedico, Karan Patel, Daniel B Buchalter, David J Kirby, Devan Mehta, John F Dankert, Emma Muiños-López, Yael Ihejirika & Philipp Leucht. (2023) Non-psychoactive Cannabidiol Prevents Osteoporosis in an Animal Model and Increases Cell Viability, Proliferation, and Osteogenic Gene Expression in Human Skeletal Stem and Progenitor Cells. Calcified Tissue International 112:6, pages 716-726.
Crossref
Crossref
Lina Yu, Liting Zeng, Zeyu Zhang, Guanxiong Zhu, Zidan Xu, Junyi Xia, Jinlong Weng, Jiang Li & Janak Lal Pathak. (2023) Cannabidiol Rescues TNF-α-Inhibited Proliferation, Migration, and Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells. Biomolecules 13:1, pages 118.
Crossref
Crossref
Meipeng Zhu, Qian Guo, Honglei Kang, Renpeng Peng, Yimin Dong, Yayun Zhang, Sibo Wang, Haiyang Liu, Hongjian Zhao, Zijian Dong, Kehan Song, Shimeng Xu, Pengju Wang, Liangxi Chen, Jian Liu & Feng Li. (2022)
Inhibition of
FAAH
suppresses
RANKL
‐induced osteoclastogenesis and attenuates ovariectomy‐induced bone loss partially through repressing the
IL17
pathway
. The FASEB Journal 37:1.
Crossref
Crossref
María Gómez-Cañas, Carmen Rodríguez-Cueto, Valentina Satta, Inés Hernández-Fisac, Elisa Navarro & Javier Fernández-Ruiz. 2023. Endocannabinoid Signaling. Endocannabinoid Signaling
67
94
.
Grace Clouse, Samantha Penman, Michael Hadjiargyrou, David E. Komatsu & Panayotis K. Thanos. (2022) Examining the role of cannabinoids on osteoporosis: a review. Archives of Osteoporosis 17:1.
Crossref
Crossref
Marlissa A. Campbell, Poorni Iyer, Farla Kaufman, Allegra Kim, Francisco Moran, Yassaman Niknam, Lily Wu, Martha S. Sandy & Lauren Zeise. (2022)
Animal evidence considered in determination of cannabis smoke and
Δ
9
‐tetrahydrocannabinol as causing reproductive toxicity (developmental endpoint); Part I. Somatic development
. Birth Defects Research 114:18, pages 1143-1154.
Crossref
Crossref
Chandler A. Sparks, Hailey M. Streff, Derrick W. Williams, Cynthia A. Blanton & Annette M. Gabaldón. (2022) Dietary Hempseed Decreases Femur Maximum Load in a Young Female C57BL/6 Mouse Model but Does Not Influence Bone Mineral Density or Micro-Architecture. Nutrients 14:20, pages 4224.
Crossref
Crossref
Farah Meah, Michelle Lundholm, Nicholas Emanuele, Hafsa Amjed, Caroline Poku, Lily Agrawal & Mary Ann Emanuele. (2021) The effects of cannabis and cannabinoids on the endocrine system. Reviews in Endocrine and Metabolic Disorders 23:3, pages 401-420.
Crossref
Crossref
Bitya Raphael-Mizrahi, Malka Attar-Namdar, Mukesh Chourasia, Maria G Cascio, Avital Shurki, Joseph Tam, Moshe Neuman, Neta Rimmerman, Zvi Vogel, Arie Shteyer, Roger G Pertwee, Andreas Zimmer, Natalya M Kogan, Itai Bab & Yankel Gabet. (2022) Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2. eLife 11.
Crossref
Crossref
Jianchao Qi, Zhe Zheng, Liqiu Hu, Huizhen Wang, Bin Tang & Lijun Lin. (2022) Development and characterization of cannabidiol-loaded alginate copper hydrogel for repairing open bone defects in vitro. Colloids and Surfaces B: Biointerfaces 212, pages 112339.
Crossref
Crossref
Nicholas Márquez-Grant, Elisa Baldini, Victoria Jeynes, Lucie Biehler-Gomez, Layla Aoukhiyad, Nicholas V. Passalacqua, Gaia Giordano, Domenico Di Candia & Cristina Cattaneo. (2022) How Do Drugs Affect the Skeleton? Implications for Forensic Anthropology. Biology 11:4, pages 524.
Crossref
Crossref
David M. Heath, Ezekial J. Koslosky, Katherine C. Bartush & Grant D. Hogue. (2022) Marijuana in Orthopaedics: Effects on Bone Health, Wound-Healing, Surgical Complications, and Pain Management. JBJS Reviews 10:2.
Crossref
Crossref
Danny Mangual-Pérez, Ruben Tresgallo-Parés, Manuel Ramírez-González, Norberto J. Torres-Lugo, Asdrúbal Rivera-Dones, Gustavo Rivera-Rodríguez, Alexandra Claudio-Marcano & Luis Lojo-Sojo. (2022) Patient Experience and Perspective on Medical Cannabis as an Alternative for Musculoskeletal Pain Management. JAAOS: Global Research and Reviews 6:7.
Crossref
Crossref
Sean G. Sheppard, Pelle V. Wall, Benjamin Wheatley & William Kent. (2021) Effects of Marijuana Use in Patients with Orthopaedic Trauma. JBJS Reviews 9:12.
Crossref
Crossref
Federica Saponaro, Rebecca Ferrisi, Francesca Gado, Beatrice Polini, Alessandro Saba, Clementina Manera & Grazia Chiellini. (2021) The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders. International Journal of Molecular Sciences 22:22, pages 12374.
Crossref
Crossref
Henry Lowe, Ngeh Toyang, Blair Steele, Joseph Bryant, Wilfred Ngwa & Kaveh Nedamat. (2021) The Current and Potential Application of Medicinal Cannabis Products in Dentistry. Dentistry Journal 9:9, pages 106.
Crossref
Crossref
Magdalena Kostrzewa, Ali Mokhtar Mahmoud, Roberta Verde, Federica Scotto di Carlo, Fernando Gianfrancesco, Fabiana Piscitelli & Alessia Ligresti. (2021) Modulation of Endocannabinoid Tone in Osteoblastic Differentiation of MC3T3-E1 Cells and in Mouse Bone Tissue over Time. Cells 10:5, pages 1199.
Crossref
Crossref
Benjamin Brennecke, Thais Gazzi, Kenneth Atz, Jürgen Fingerle, Pascal Kuner, Torsten Schindler, Guy de Weck, Marc Nazaré & Uwe Grether. (2021) Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010. Pharmaceutical Patent Analyst 10:3, pages 111-163.
Crossref
Crossref
Garwin Chin, Brent A. F. Etiz, Ariana M. Nelson, Philip K. Lim & John A. Scolaro. (2021) Knowledge and Opinion on Cannabinoids Among Orthopaedic Traumatologists. JAAOS: Global Research and Reviews 5:4.
Crossref
Crossref
J. Stewart Buck, Ainsley K. Bloomer, Meghan K. Wally, Rachel B. Seymour & Joseph R. Hsu. (2020) The Current Evidence for Marijuana as Medical Treatment. Journal of Bone and Joint Surgery 102:23, pages 2096-2105.
Crossref
Crossref
Bitya Raphael-Mizrahi & Yankel Gabet. (2020) The Cannabinoids Effect on Bone Formation and Bone Healing. Current Osteoporosis Reports 18:5, pages 433-438.
Crossref
Crossref
Ellen Otto, Paul-Richard Knapstein, Denise Jahn, Jessika Appelt, Karl-Heinz Frosch, Serafeim Tsitsilonis & Johannes Keller. (2020) Crosstalk of Brain and Bone—Clinical Observations and Their Molecular Bases. International Journal of Molecular Sciences 21:14, pages 4946.
Crossref
Crossref
Silvia Marino, Giovana Carrasco, Boya Li, Karan M. Shah, Darren L. Lath, Antonia Sophocleous, Michelle A. Lawson & Aymen I. Idris. (2020) JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice. Calcified Tissue International 107:1, pages 72-85.
Crossref
Crossref
John J. Carney, Alan Hwang, Nathanael Heckmann, Mitchell Bernstein & Geoffrey S. Marecek. (2020) Characteristics of Marijuana Use Among Orthopedic Patients. Orthopedics 43:2, pages 108-112.
Crossref
Crossref
Joel Ehrenkranz & Michael A Levine. (2019) Bones and Joints: The Effects of Cannabinoids on the Skeleton. The Journal of Clinical Endocrinology & Metabolism 104:10, pages 4683-4694.
Crossref
Crossref
Amir Kamali, Ahmad Oryan, Samaneh Hosseini, Mohammad Hossein Ghanian, Maryam Alizadeh, Mohamadreza Baghaban Eslaminejad & Hossein Baharvand. (2019) Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects. Materials Science and Engineering: C 101, pages 64-75.
Crossref
Crossref
Terézia Kisková, Felicitas Mungenast, Mária Suváková, Walter Jäger & Theresia Thalhammer. (2019) Future Aspects for Cannabinoids in Breast Cancer Therapy. International Journal of Molecular Sciences 20:7, pages 1673.
Crossref
Crossref
Thomas M. ClarkJessica M. JonesAlexis G. HallSara A. TabnerRebecca L. Kmiec. (2018)
Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in
Cannabis
Users
. Cannabis and Cannabinoid Research 3:1, pages 259-271.
Crossref
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
Crossref
Barbara Scolnick. (2018) Treatment of anorexia nervosa with palmitoylethanoamide. Medical Hypotheses 116, pages 54-60.
Crossref
Crossref
Nirajan Shrestha, James S.M. Cuffe, Dana S. Hutchinson, John P. Headrick, Anthony V. Perkins, Andrew J. McAinch & Deanne H. Hryciw. (2018) Peripheral modulation of the endocannabinoid system in metabolic disease. Drug Discovery Today 23:3, pages 592-604.
Crossref
Crossref
Saif Deis, Raj Kamal Srivastava, Inigo Ruiz de Azua, Laura Bindila, Saja Baraghithy, Beat Lutz, Itai Bab & Joseph Tam. (2018) Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor. Bone 108, pages 34-42.
Crossref
Crossref
Sara Jane Ward, Francesca Castelli, Zachary W. Reichenbach & Ronald F. Tuma. (2018) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sciences 195, pages 1-5.
Crossref
Crossref
Donald Bourne, Wesley Plinke, Elizabeth R. Hooker & Carrie M. Nielson. (2017) Cannabis use and bone mineral density: NHANES 2007–2010. Archives of Osteoporosis 12:1.
Crossref
Crossref
Antonia Sophocleous, Silvia Marino, Dilruba Kabir, Stuart H. Ralston & Aymen I. Idris. (2017) Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition. Aging Cell 16:5, pages 1051-1061.
Crossref
Crossref
Cui’e Lu, Linyu Shi, Bei Sun, Yu Zhang, Bailing Hou, Yu’e Sun, Zhengliang Ma & Xiaoping Gu. (2016) A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2. Cellular and Molecular Neurobiology 37:1, pages 101-109.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Aysha B. Khalid, Simon R. Goodyear, Ruth A. Ross & Richard M. Aspden. (2016) Mechanical and material properties of cortical and trabecular bone from cannabinoid receptor-1-null (Cnr1−/−) mice. Medical Engineering & Physics 38:10, pages 1044-1054.
Crossref
Crossref
Andreas Zimmer. (2016) A collaboration investigating endocannabinoid signalling in brain and bone. Journal of Basic and Clinical Physiology and Pharmacology 27:3, pages 229-235.
Crossref
Crossref
Raphael Mechoulam. (2016) Cannabis – the Israeli perspective. Journal of Basic and Clinical Physiology and Pharmacology 27:3, pages 181-187.
Crossref
Crossref
Bitya Raphael & Yankel Gabet. (2016) The skeletal endocannabinoid system: clinical and experimental insights. Journal of Basic and Clinical Physiology and Pharmacology 27:3, pages 237-245.
Crossref
Crossref
Aritz Lopategi, Cristina López-Vicario, José Alcaraz-Quiles, Verónica García-Alonso, Bibiana Rius, Esther Titos & Joan Clària. (2016) Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Molecular and Cellular Endocrinology 419, pages 44-59.
Crossref
Crossref
Matthias Nettekoven, Jean‐Michel Adam, Stefanie Bendels, Catarina Bissantz, Jürgen Fingerle, Uwe Grether, Sabine Grüner, Wolfgang Guba, Atsushi Kimbara, Giorgio Ottaviani, Bernd Püllmann, Mark Rogers‐Evans, Stephan Röver, Benno Rothenhäusler, Sebastien Schmitt, Franz Schuler, Tanja Schulz‐Gasch & Christoph Ullmer. (2015) Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases. ChemMedChem 11:2, pages 179-189.
Crossref
Crossref
Natalya M Kogan, Eitan Melamed, Elad Wasserman, Bitya Raphael, Aviva Breuer, Kathryn S Stok, Rachel Sondergaard, Ana VVillarreal Escudero, Saja Baraghithy, Malka Attar-Namdar, Silvina Friedlander-Barenboim, Neashan Mathavan, Hanna Isaksson, Raphael Mechoulam, Ralph Müller, Alon Bajayo, Yankel Gabet & Itai Bab. (2015) Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts. Journal of Bone and Mineral Research 30:10, pages 1905-1913.
Crossref
Crossref
Marie Smith, Richard Wilson, Sally O’Brien, Cristina Tufarelli, Susan I. Anderson & Saoirse Elizabeth O’Sullivan. (2015) The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation. PLOS ONE 10:9, pages e0136546.
Crossref
Crossref
Francesca Rossi, Giulia Bellini, Chiara Tortora, Maria Ester Bernardo, Livio Luongo, Antonella Conforti, Nadia Starc, Iolanda Manzo, Bruno Nobili, Franco Locatelli & Sabatino Maione. (2015) CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity. Pharmacological Research 99, pages 194-201.
Crossref
Crossref
Mauro Maccarrone, Itai Bab, Tamás Bíró, Guy A. Cabral, Sudhansu K. Dey, Vincenzo Di Marzo, Justin C. Konje, George Kunos, Raphael Mechoulam, Pal Pacher, Keith A. Sharkey & Andreas Zimmer. (2015) Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences 36:5, pages 277-296.
Crossref
Crossref
Bruce A. Watkins & Jeffrey Kim. (2015) The endocannabinoid system: directing eating behavior and macronutrient metabolism. Frontiers in Psychology 5.
Crossref
Crossref
Elad Wasserman, Joseph Tam, Raphael Mechoulam, Andreas Zimmer, Gila Maor & Itai Bab. (2015) CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol. Annals of the New York Academy of Sciences 1335:1, pages 110-119.
Crossref
Crossref
Jeremiah J. Harnett, Christine Dolo, Isabelle Viossat, Florence Auger, Eric Ferrandis, Dennis Bigg, Michel Auguet, Serge Auvin & Pierre-E. Chabrier. (2015) Novel azoles as potent and selective cannabinoid CB2 receptor agonists. Bioorganic & Medicinal Chemistry Letters 25:1, pages 88-91.
Crossref
Crossref
Richard Hallinan. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
1757
1787
.
I. ŽOFKOVÁ & P. MATUCHA. (2014) New Insights Into the Physiology of Bone Regulation: the Role of Neurohormones. Physiological Research, pages 421-427.
Crossref
Crossref
F Rossi, G Bellini, M Torella, C Tortora, I Manzo, C Giordano, F Guida, L Luongo, F Papale, F Rosso, B Nobili & S Maione. (2014) The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. British Journal of Pharmacology 171:10, pages 2621-2630.
Crossref
Crossref
Miles D. Thompson, David E. C. Cole, Valerie Capra, Katherine A. Siminovitch, G. Enrico Rovati, W. McIntyre Burnham & Brinda K. Rana. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
189
242
.
Florent Elefteriou & Gerard Karsenty. 2013. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
82
89
.
Pál Pacher & George Kunos. (2013) Modulating the endocannabinoid system in human health and disease – successes and failures. The FEBS Journal 280:9, pages 1918-1943.
Crossref
Crossref
Peng Yang, Liping Wang, Rentian Feng, Abdulrahman A. Almehizia, Qin Tong, Kyaw-Zeyar Myint, Qin Ouyang, Mohammed Hamed Alqarni, Lirong Wang & Xiang-Qun Xie. (2013) Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonists and Osteoclast Inhibitors: Discovery, Optimization, and Biological Evaluation. Journal of Medicinal Chemistry 56:5, pages 2045-2058.
Crossref
Crossref
Matthias Nettekoven, Jürgen Fingerle, Uwe Grether, Sabine Grüner, Atsushi Kimbara, Bernd Püllmann, Mark Rogers-Evans, Stephan Röver, Franz Schuler, Tanja Schulz-Gasch & Christoph Ullmer. (2013) Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening. Bioorganic & Medicinal Chemistry Letters 23:5, pages 1177-1181.
Crossref
Crossref
Francesca Rossi, Giulia Bellini, Livio Luongo, Silvia Mancusi, Marco Torella, Chiara Tortora, Iolanda Manzo, Francesca Guida, Bruno Nobili, Vito de Novellis & Sabatino Maione. (2013) The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. Pharmacological Research 68:1, pages 7-15.
Crossref
Crossref
C. van der Leeuw, P. Habets, P. Domen, M. van Kroonenburgh, J. van Os & M. Marcelis. (2013) Bone mineral density as a marker of cumulative endogenous estrogen exposure: Relationship to background genetic risk of psychotic disorder. Schizophrenia Research 143:1, pages 25-31.
Crossref
Crossref
Roger G. Pertwee. (2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philosophical Transactions of the Royal Society B: Biological Sciences 367:1607, pages 3353-3363.
Crossref
Crossref
Brady K. Atwood, Alex Straiker & Ken Mackie. (2012) CB2: Therapeutic target-in-waiting. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38:1, pages 16-20.
Crossref
Crossref
LS Whyte, L Ford, SA Ridge, GA Cameron, MJ Rogers & RA Ross. (2012)
Cannabinoids and bone: endocannabinoids modulate human osteoclast function
in vitro
. British Journal of Pharmacology 165:8, pages 2584-2597.
Crossref
Crossref
Christian Ndong, Dajan O'Donnell, Sultan Ahmad & Thierry Groblewski. (2011) Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor. European Journal of Pharmacology 669:1-3, pages 24-31.
Crossref
Crossref
Antoni R. Blaazer, Jos H.M. Lange, Martina A.W. van der Neut, Arie Mulder, Femke S. den Boon, Taco R. Werkman, Chris G. Kruse & Wytse J. Wadman. (2011) Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity. European Journal of Medicinal Chemistry 46:10, pages 5086-5098.
Crossref
Crossref
Wolfgang Schuehly, Juan Manuel Viveros Paredes, Jonas Kleyer, Antje Huefner, Sharon Anavi-Goffer, Stefan Raduner, Karl-Heinz Altmann & Jürg Gertsch. (2011) Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB2 Receptor Inverse Agonists. Chemistry & Biology 18:8, pages 1053-1064.
Crossref
Crossref
Francesca Rossi, Giulia Bellini, Livio Luongo, Marco Torella, Silvia Mancusi, Luciano De Petrocellis, Stefania Petrosino, Dario Siniscalco, Pierangelo Orlando, Mariantonietta Scafuro, Nicola Colacurci, Silverio Perrotta, Bruno Nobili, Vincenzo Di Marzo & Sabatino Maione. (2011) The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy. Bone 48:5, pages 997-1007.
Crossref
Crossref
. 2011. A Guide to Evidence-based Integrative and Complementary Medicine. A Guide to Evidence-based Integrative and Complementary Medicine
694
714
.
Jane B. Lian, Ellen M. Gravallese & Gary S. Stein. 2011. Osteoimmunology. Osteoimmunology
101
140
.
R. G. Pertwee, A. C. Howlett, M. E. Abood, S. P. H. Alexander, V. Di Marzo, M. R. Elphick, P. J. Greasley, H. S. Hansen, G. Kunos, K. Mackie, R. Mechoulam & R. A. Ross. (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB
1
and CB
2
. Pharmacological Reviews 62:4, pages 588-631.
Crossref
Crossref